Impact of Viruses on Neurodegenerative Diseases
Link Between Viral Infections and Neurodegenerative Diseases
Recent research indicates that certain viruses may elevate the risk of developing neurodegenerative diseases (NDDs) such as Alzheimer’s, multiple sclerosis, Parkinson’s disease, vascular dementia, and amyotrophic lateral sclerosis (ALS). Investigators examined a vast health information repository, which included data from over 300,000 patients diagnosed with NDDs who had previously been hospitalized due to viral infections.
Findings on Viral Associations with NDDs
The study revealed more than 45 significant associations between viral infections and NDDs. Notably, viral encephalitis, influenza, and pneumonia were linked to these diseases. Individuals with a history of viral encephalitis had a higher likelihood of being diagnosed with Alzheimer’s. Influenza emerged as the most common viral infection, showing significant correlations with five of the six NDDs analyzed. Viral encephalitis presented the highest risk for neurodegenerative diseases, particularly Alzheimer’s, while the link between dementia and influenza showed moderate risk.
Understanding the Virus-NDD Relationship
Mechanism of Impact
The connection between viral infections and NDDs is thought to arise from the immune response triggered by the viruses, which may preferentially target the nervous system. Once viral proteins infiltrate the central nervous system (CNS), they can induce significant inflammation in the brain and its surrounding protective tissues. SARS-CoV-2 is one of three viruses known to disrupt protein quality, leading to the accumulation and misfolding of proteins, which progressively damages brain structure, function, and cognition. This inflammation can result in cell death and impair communication within the brain and nervous system. Although these effects are generally temporary, certain viral infections can become chronic, leading to lasting impairment of the brain and CNS.
Strategies for Neurodegenerative Disease Prevention
Monitoring and Vaccination
Research suggests that monitoring risk factors and utilizing antiviral medications may be effective in reducing the risk of developing neurodegenerative diseases. Vaccination has been identified as one of the most effective preventive measures against NDDs related to viral infections. Currently, vaccines are available for several viruses, helping to decrease viral transmission and the viral load during infections.
Future Research Directions
Despite the established relationship between viral infections and neurodegenerative diseases, it remains unclear whether viral infections influence disease prognosis or if early exposure to viruses correlates with the development of NDDs. However, evidence supports that vaccinations can prevent serious complications and hospitalizations, emphasizing the importance of staying current with vaccinations.
References
1. National Institute on Aging. Could a viral illness increase chances of developing Alzheimer’s or other neurodegenerative diseases? Retrieved from https://www.nia.nih.gov/news/could-viral-illness-increase-chances-developing-alzheimers-or-other-neurodegenerative-disease. Published January 19, 2023.
2. Levine K, et al. (2022). Virus exposure and neurodegenerative disease risk across national biobanks. BMJ. https://doi.org/10.1101/2022.07.08.22277373
3. Sousa IP & Ramos Goncalves Vieira TC. (2023). Enterovirus infection and its relationship with neurodegenerative diseases. Mem Inst Oswaldo Cruz, 118. https://doi.org/10.1590/0074-02760220252
4. Röme C. (2021). Viruses and endogenous retroviruses as roots for neuroinflammation and neurodegenerative diseases. Frontiers in Neuroscience, 15. https://doi.org/10.3389/fnins.2021.648629
5. Leblanc P, Vorberg IM (2022) Viruses in neurodegenerative diseases: More than just suspects in crimes. PLoS Pathog 18(8): e1010670. https://doi.org/10.1371/journal.ppat.1010670